GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Genomic Health, Inc. (GHDX) [hlAlert]

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It
launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.
( Total: 24 Current Stock Recommendations )
Genomic Health, Inc.   (24)
Sell 17% Hold 42% Buy 42%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Buy GHDX
down 23.62 %

Rating:
Buy GHDX
down 11.69 %

Rating:
Sell GHDX
down 2.02 %

Rating:
Hold GHDX

Rating:
Hold GHDX
down 23.90 %

Rating:
Sell GHDX
up 11.29 %

Rating:
Sell GHDX
up 16.31 %
Genomic Health, Inc. (GHDX) rated Underperform by Raymond James
Monday,  Sep 23, 2013  8:25 AM ET

Rating:
Hold GHDX

Rating:
Sell GHDX
up 23.45 %
Genomic Health, Inc. (GHDX) downgraded to Sell by Goldman
Tuesday,  Jun 25, 2013  8:25 AM ET

Rating:
Hold GHDX

Rating:
Hold GHDX
Genomic Health, Inc. (GHDX) rated Hold by Jefferies
Friday,  May 31, 2013  8:25 AM ET

Rating:
Buy GHDX
down 4.80 %

Rating:
Hold GHDX
Genomic Health, Inc. (GHDX) rated Neutral by Goldman
Thursday,  Oct 11, 2012  8:25 AM ET

Rating:
Buy GHDX
down 23.90 %
Genomic Health, Inc. (GHDX) rated Outperform by Credit Suisse
Tuesday,  Sep 25, 2012  8:25 AM ET

Rating:
Buy GHDX
down 8.30 %
Genomic Health, Inc. (GHDX) rated Buy by BofA/Merrill
Thursday,  Aug 16, 2012  8:25 AM ET

Your Recent Stocks
SymbolLastChange
GHDX 26.67 down  -0.22 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy